Health Care & Life Sciences » Pharmaceuticals | Unigene Laboratories Inc.

Unigene Laboratories Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2008
2009
2010
2011
2012
Net Income before Extraordinaries
6,078.40
13,379.70
27,868.50
17,925.70
34,286.20
Depreciation, Depletion & Amortization
903.00
732.50
965.00
709.60
844.00
Other Funds
610.30
1,779.20
13,337.90
1,327.70
15,987.10
Funds from Operations
5,785.70
14,426.50
13,565.60
18,543.80
17,455.10
Changes in Working Capital
2,789.50
3,135.70
11,897.10
11,777.40
14,277.90
Net Operating Cash Flow
8,575.20
11,290.80
1,668.50
6,766.40
3,177.20
Capital Expenditures
1,961.70
791.50
678.50
988.10
381.90
Purchase/Sale of Investments
-
-
-
2,819.10
707.00
Net Investing Cash Flow
2,545.20
3,030.20
678.50
2,673.20
1,088.90
Issuance/Reduction of Debt, Net
14,087.20
4,240.60
9,580.30
-
3,384.80
Net Financing Cash Flow
16,025.90
4,571.60
9,653.60
1,920.40
3,397.90
Net Change in Cash
4,905.60
3,689.00
7,306.60
7,519.10
868.20
Free Cash Flow
9,981.30
11,587.70
1,815.90
7,461.00
3,413.50
Other Sources
-
4,139.10
-
1,140.00
-
Change in Capital Stock
1,938.70
330.90
73.30
1,920.40
13.10
Other Uses
583.50
317.40
-
5.90
-
Miscellaneous Funds
-
-
-
0.00
0.00

About Unigene Laboratories

View Profile
Address
81 Fulton Street
Boonton New Jersey 07005
United States
Employees -
Website -
Updated 09/14/2018
Unigene Laboratories, Inc. is a biopharmaceutical company, which engages in the designing, delivering, manufacturing and development of peptide-based therapeutics. The company was founded by Jay Levy, Ronald S. Levy and Warren P.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.